Bringing peripheral nerve disorders to the center

Advancing genetic therapies for peripheral nerve disorders starting with Neurofibromatosis type 1

Founding Partners

Team

Gonzalo Fernández-Miranda  

CEO and co-Founder

Gonzalo is an accomplished expert in company creation and entrepreneurship, having co-founded Ninevah and Nanobots Therapeutics. With a successful exit and experience in executive roles, he brings extensive expertise in rare diseases, RNA therapeutics and gene therapy.

Liron Elkouby

CTO and co-Founder

Liron is a gene and cell therapy expert with 13+ years of experience in rare diseases. She has held key roles at multiple gene therapy companies, including Spark Therapeutics, and co-founded Noga, where she served as CSO. She led the development of a hemophilia gene therapy asset licensed to Pfizer.

Kerstin Papenfuss

Board Director

Kerstin is Director of Pharma at Deep Science Ventures. She has extensive experience building, launching and supporting over a dozen biotechs in advanced cell and gene therapies. Kerstin was recently recognized as impactful female leader by the Global Leader Magazine.

Montse Montaner

Board Director

Montse, co-Chair of the Business Advisory Council at the Children’s Tumor Foundation, has 20+ years of big pharma experience, including as Chief of Quality and Sustainability in Novartis. A trusted advisor to executives and boards, she excels in compliance, operational excellence, and business transformation.